Skip to main content
Contact Us
Subscribe
e-Edition
Sign Up
Log In
Dashboard
Logout
My Account
Dashboard
Profile
Saved items
Logout
Facebook
Site search
Search
Menu
Subscribe
Home
Contact Us
Terms of Use
Privacy Policy
Home Delivery
Subscribe
Submission Forms
Place an Ad
Weather
News
Sports
Entertainment
Calendar
Obituaries
Classifieds
Place an ad
e-Edition
Best of 2023
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Latest News about Novo Nordisk A/S
Recent news which mentions Novo Nordisk A/S
< Previous
1
2
3
4
5
6
Next >
Patients regain weight after stopping Eli Lilly's Zepbound, study says
December 11, 2023
Tags
US: News
Companies
Biotechnology
From
CNBC.com News
Eli Lilly weight loss drug Zepbound now available at pharmacies as rival Wegovy faces shortages
December 05, 2023
Tags
Novo Nordisk A/S
Biotech and Pharmaceuticals
Cigna Corp
From
CNBC.com News
An EU wealth tax and the end of U.S. capitalism: One bank’s ‘outrageous’ predictions for 2024
December 05, 2023
Tags
Economy
Breaking News: Politics
US Economy
From
CNBC.com News
Cramer says the growing popularity of weight loss drugs brings new investing opportunities
December 04, 2023
Tags
Business News
U/S/ Markets
Hormel Foods Corp
From
CNBC.com News
Pfizer's twice-daily weight loss pill joins a long list of obesity drug flops
December 02, 2023
Tags
Pharmaceuticals
Business
Sanofi SA
From
CNBC.com News
Pfizer to discontinue twice-daily weight loss pill due to high rates of adverse side effects
December 01, 2023
Tags
Pharmaceuticals
Weight management
Business
From
CNBC.com News
Novo Nordisk sues two pharmacies for allegedly selling tainted Wegovy, Ozempic knockoffs
November 30, 2023
Tags
Companies
US: News
Biotechnology
From
CNBC.com News
Mounjaro is more effective than Ozempic for weight loss in overweight and obese adults, real world study says
November 27, 2023
Tags
Business News
Health & Science
Biotechnology
From
CNBC.com News
Jim Cramer says insurance companies will pay for 'revolutionary' weight-loss drugs for their members
November 13, 2023
Tags
Novo Nordisk A/S
Markets
Stock Picks
From
CNBC.com News
Pfizer wants in on the weight loss drug market – and upcoming data will be crucial for its success
November 13, 2023
Tags
Eli Lilly and Co
Health care industry
Pfizer Inc
From
CNBC.com News
5 things to know before the stock market opens Monday
November 13, 2023
Tags
Macy's Inc
Politics
Markets
From
CNBC.com News
Novo Nordisk's weight loss drug Wegovy slashes risk of serious heart events
November 11, 2023
Tags
Health & Science
Novo Nordisk A/S
Business News
From
CNBC.com News
Cramer's week ahead: Consumer spending in the spotlight with retail earnings and a new price index
November 10, 2023
Tags
Business News
U/S/ Markets
Investing
From
CNBC.com News
Cramer's Lightning Round: Buy AutoZone
November 09, 2023
Tags
Snowflake Inc/
Aehr Test Systems
S&P 500
From
CNBC.com News
FDA approves Eli Lilly's tirzepatide for obesity, paving way for even wider use of blockbuster drug
November 08, 2023
Tags
Companies
US: News
Biotechnology
From
CNBC.com News
Novo Nordisk says 80% of insured U.S. patients taking Wegovy pay less than $25 a month
November 02, 2023
Tags
Pharmaceuticals
Business
Breaking news
From
CNBC.com News
Eli Lilly says supply of blockbuster diabetes drug Mounjaro has improved in U.S.
November 02, 2023
Tags
Novo Nordisk A/S
Pfizer Inc
Biotech and Pharmaceuticals
From
CNBC.com News
Weight-loss drug Wegovy could get expanded FDA approval within six months, Novo Nordisk says
November 02, 2023
Tags
US Top News and Analysis
Biotechnology
US: News
From
CNBC.com News
Eli Lilly results top estimates on Mounjaro strength but slashes full-year profit outlook
November 02, 2023
Tags
Biotech and Pharmaceuticals
Novo Nordisk A/S
Earnings
From
CNBC.com News
Pfizer swings to quarterly loss due to Paxlovid, Covid vaccine write-offs
October 31, 2023
Tags
Business
Pharmaceuticals
Breaking news
From
CNBC.com News
As Ozempic and Wegovy take off, this tech startup just raised $20 million to tackle weight loss with data
October 24, 2023
Tags
Weight management
Abbott Laboratories
Health & Science
From
CNBC.com News
CNBC Daily Open: Oil deals ahead of Big Tech earnings
October 24, 2023
Tags
Advanced Micro Devices Inc
Tesla Inc
Chevron Corp
From
CNBC.com News
CNBC Daily Open: Oil deals and awaiting tech earnings
October 23, 2023
Tags
Inflation
Consumer prices
Tesla Inc
From
CNBC.com News
Wall Street hikes forecasts for anti-obesity drug sales to $100 billion and beyond — A look at the numbers
October 23, 2023
Tags
Investment strategy
Investing
Novo Nordisk A/S
From
CNBC.com News
Sanofi to offer insulin product for $35 to all Americans through GoodRx
October 19, 2023
Tags
CVS Health Corp
Eli Lilly and Co
Health care industry
From
CNBC.com News
'Miracle drug' euphoria: Experts warn widespread use of weight loss medicine faces major hurdles
October 14, 2023
Tags
Biotech and Pharmaceuticals
Novo Nordisk A/S
Medication
From
CNBC.com News
Novo Nordisk hikes outlook on soaring demand for Wegovy, Ozempic
October 13, 2023
Tags
Companies
US: News
Biotechnology
From
CNBC.com News
Tempest Therapeutics, Microsoft, Birkenstock, Novo Nordisk, Tesla: Why These 5 Stocks Are On Investors' Radars Today
October 11, 2023
Tickers
BIRK
EVS
MSFT
NVO
Tags
NVO
MSFT
Equities
From
Benzinga
How is the rise of GLP-1 weight loss drugs affecting market action? Jim Cramer explains
October 11, 2023
Tags
Novo Nordisk A/S
Dexcom Inc
Stock Picks
From
CNBC.com News
Stocks making the biggest moves midday: Novo Nordisk, DaVita, Exxon Mobil, Amgen and more
October 11, 2023
Tags
Eli Lilly and Co
Exxon Mobil Corp
Pioneer Natural Resources Co
From
CNBC.com News
< Previous
1
2
3
4
5
6
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.